MOLECULAR IDENTIFICATION OF ROSEOMONAS MUCOSA AND DETERMINATION THE SOME OF ITS VIRULENCE FACTORS
DOI:
https://doi.org/10.36103/ijas.v54i2.1734Keywords:
Roseomonas sp., antimicrobial susceptibility test, capsular detection and biofilm formation.Abstract
This study was aimed to characterize Roseomonas mucosa isolate using molecular genetics and determination some bacterial virulence factors such as capsular, biofilm formation and antimicrobial susceptibility. By using Polymerase chain reaction (PCR) technique, the molecular characterization of the R. mucosa was done by using 16S rRNA gene sequence and phylogenetic analysis. Antimicrobial susceptibility test was carried out by Kirby-Bauer disk diffusion method. Capsular detection was examined using nigrosin pigment. While Congo red agar and microtiter plate using enzyme-linked immunosorbent assay (ELISA) reader methods are used to determined bacterial isolate capability to produce a biofilm. The molecular characterization shows the bacterium that isolated from catheter of a dialysis Iraqi patient is belong to Roseomonas mucosa. The isolated R. mucosa strain showed resistant to Amoxicillin, methicillin, carbapenemes, bacitracin and Sulfamethoxazole. While it was susceptible to tobramycin, levofloxacin, colisitin sulphate, doxycycline, azithromycin and cephalexin. The results show R. mucosa was encapsulated. Furthermore, it has the ability to form weak biofilm. The findings suggest that in spite of this genus seems to have an overall little pathogenic potential for humans, Roseomonas sp. in particular, R. mucosa may be substantial pathogens in individuals with underlying medical complications.
References
Aditya K, D Neha, A Nishant, G Meetu and SI Yogendra. 2017. Bacterial virulence factors: Secreted for surviva Indian J Microbiol. Indian J Microbiol: 57(1):1–10.
Alcala L, F Vasallo, E Cercenado, F Garcia- Garrote, M Rodriguez-Creixems and E Bouza. 1997. Letter to the Editor. Catheter-related bacteremia due to Roseomonas gilardii sp. nov. J Clin Microbiol, 35(10):2712.
Bauer A, WM Kirby, J Sherris and M Turck. 1996. Antibiotic susceptibility test by a standardized single disk method. American j of clin pathol, 45(4):493-496.
Dien B, J Deville, P Summanen and M Lewinski. A. 2010. Roseomonas mucosa Isolated from bloodstream of pediatric patient. Journal of clinical microbio;ogy, 48(8):3027– 3029.
Diesendorf N, S Kohler, G Walter, G Tanja, K Matthias and B Andreas. 2017. Characterisation of Roseomonas mucosa Isolated from the root canal of an infected tooth, BMC Research Notes, 10(1):212.
Donohue D and S Salminen. 1996. Safety of Probiotic Bacteria. Asia Pac J Clin Nutr, 5(1):25-8.
Freeman D, F Falkiner and C Keane. 1989. New method for detecting slime production by coagulase negative Staphylococci. J Clin Pathol, 42(8):872-4.
Hamza M and L Yaaqoob. 2020. Evaluation the Effect of Green Synthesis Titanium Dioxide Nanoparticles on acinetobacter baumannii Isolates. Iraqi Journal of Agricultural Sciences, 51(6):1486-1495. https://doi.org/10.36103/ijas.v51i6.1176
Han X, A Pham, J Tarrand, K Rolston, L Helsel and Levett PN. 2003. Bacteriologic characterization of 36 strains of Roseomonas species and proposal of Roseomonas mucosa sp nov and Roseomonas gilardii subsp rosea subsp nov. Am J Clin Pathol, 120(2):256-64.
Indra D and V Kenneth. 2004. Rolston, Xiang Y. Han2. Clinical Significance of Roseomonas Species Isolated from catheter and blood samples: Analysis of 36 cases in Pa- tients with Cancer. Clin Infect Dis, 38(11):1579-84.
Jorge H. 2020. Microbial Virulence Factors. Int. J. Mol. Sci, 21(15):5320.
Katsunori F, G Keiichi, K Yuko, S Keiko, S Junichi, H Motonobu, Y Shinichi and F Masafumi. 2007. Characteristics of a pink-
pigmented bacterium isolated from biofilm in a cooling tower in tokyo, Japan. Microbiol. Immunol, 51(6):637–641.
Kim K, J Hur, W Jo, J Hong, O Cho, D Kang, S Kim and I Bae. 2015. Infectious spondylitis with bacteremia caused by Roseomonas mucosa in an immunocompetent patient. Infect Chemother, 47(3):194.
Koh O, A Alafate, S Ryoichi, U Reiko, O Hina and H Shuji. 2020. A nosocomial cluster of Roseomonas mucosa bacteremia possibly linked to contaminated hospital environment. Journal of infection and chemotherapy, 26(8):802-806.
Kumar A, N Dhasmanal, N Dubey, N Kumar, A Gangwali, M Gupta and Y Singh. 2017. Bacterial virulence factors: Secreted for survival. Indian J Microbiol, 57(1):1–10.
Mahmood H, G Nasir and Q Ibraheem. 2020. Relationship between pigments production and biofilm formation from local Pseudomonas aeruginosa isolates. Iraqi Journal of agricultural Sciences, 51(5):1413- 1419. https://doi.org/10.36103/ijas.v51i5.1151
Rihs J, D Brenner, R Weaver, A Steigerwalt, D Hollis and V Yu. 1993. Roseomonas, a new genus associated with bacteremia and other human infections. J Clin Microbiol, 31(12): 3275–3283.
Shayuan S, G Xin, G Penghao, C Yingpeng and C Yili. 2019. Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: Case report and review of literature. BMC Infectious Diseases, 19:140.
Smith. 2010. Stain protocols-BIOL 2420.
Struthers M, J Wong and J Janda. 1996. An initial appraisal of the clinical significance of Roseomonas species associated with human infections. Clin Infect Dis, 23(4):729-33
Teeba G and A Mouruj. 2021. Isolation and characterization of Roseomonas mucosa from different clinical Specimens. Psychology and education, 58(3): 1180-1186.
Venkataramana K. 2015. Bacterial capsule, colony morphology, functions, and its relation to virulence and diagnosis. Annals of Tropical Medicine and Public Health, 8(4):151-153.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.